Title : Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside.

Pub. Date : 2019

PMID : 30160213






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In contrast, safinamide is a reversible MAOB inhibitor, and also inhibits voltage- sensitive sodium channels and glutamate release. safinamide monoamine oxidase B Homo sapiens
2 Safinamide is the prototype of a new generation of multi-active MAOB inhibitors, which includes the antiepileptic drug, zonisamide. safinamide monoamine oxidase B Homo sapiens
3 Among all antiparkinsonian agents, MAOB inhibitors are those with the greatest neuroprotective potential because of inhibition of dopamine metabolism, induction of neurotrophic factors, and, in the case of safinamide, inhibition of glutamate release. safinamide monoamine oxidase B Homo sapiens